All posts by: Michael Zand

About Michael Zand

3 Things In Biotech You Should Learn Today: May 27, 2017 – Seeking Alpha

Continue reading

2017-05-27 NEWS

3 Things In Biotech You Should Learn Today: May 27, 2017
Seeking Alpha
CART cell therapy is reaching its tipping point, and we’re going to find out in 2017 if these agents are deemed to have a risk/benefit profile that is sufficient for the FDA to allow their use. Kite Pharma (NASDAQ:KITE) made a splash when they

Continue reading

2017-05-27 NEWS

IFLScience

Stem Cells Show Promise – But They Also Have A Darker Side
IFLScience
Everyone seems to be excited about stem cells. Their excellent promise as a treatment for a range of diseases and injuries mean almost guaranteed coverage for research. While some types of stem cells are already being used in treatment – for treating …

Continue reading

2017-05-27 NEWS

Los Angeles Times

Immunotherapy drug opens a new era of precision medicine for cancer
Los Angeles Times
With little fanfare, the Food and Drug Administration did something this week that it’s never done before: The agency approved a single prescription drug, pembrolizumab (marketed by Merck as Keytruda) for treatment of solid tumors in any organ so long
FDA approves cancer drug for personalized immunotherapy approachMedical Xpress
SAA Funding Contributes to FDA Approval Of KeytrudaSwimSwam
Expanded Keytruda Approval Signals New Phase for Precision Medicine, May Benefit NGS Panel MakersGenomeWeb

all 9 news articles »

Continue reading

2017-05-27 NEWS

Miami Herald

Using your immune system to fight cancer is showing significant promise
Miami Herald
What if the power to fight cancer more effectively was within you? Researchers are trying to harness that superpower, by studying how a patient’s own immune system battles cancer. “Immunotherapy is a more natural way of treating cancer, rather than …
Designer Viruses Could Help Fight CancerInverse

all 5 news articles »